Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 28, 2026; 32(44): 120795
Published online Nov 28, 2026. doi: 10.3748/wjg.120795
Published online Nov 28, 2026. doi: 10.3748/wjg.120795
Figure 3 Kaplan-Meier curves for recurrence-free survival by pathological stage after inverse probability of treatment weighting.
A: Stage I: 5-year recurrence-free survival (RFS), 93.77% vs 88.66% in early-onset gastric cancer(EOGC) and mid-aged gastric cancer (M-GC), respectively (P = 0.234); B: Stage II: 5-year RFS, 80.55% vs 64.75% in EOGC and M-GC, respectively (P = 0.136); C: Stage III: 5-year RFS in stage III, 57.62% vs 36.14% in EOGC and M-GC, respectively (P = 0.032). M-GC: Mid-aged gastric cancer; EOGC: Early-onset gastric cancer.
- Citation: Jeong SA, Lee JB, Kim JH. Clinicopathological characteristics and survival outcomes of early-onset vs mid-aged gastric cancer using an evidence-based age cutoff. World J Gastroenterol 2026; 32(44): 120795
- URL: https://www.wjgnet.com/1007-9327/full/v32/i44/120795.htm
- DOI: https://dx.doi.org/10.3748/wjg.120795